|
FDMT 4d Molecular Therapeutics Inc 1650648 |
| Balance Sheet |
|
Current Assets
|
510,757,000 |
|
Assets
|
604,028,000 |
|
Current Liabilities
|
29,465,000 |
|
Liabilities
|
51,080,000 |
|
Equity
|
552,948,000 |
|
Shares Out
|
51,970,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-88,722,000 |
|
Investing Cash Flow
|
-309,496,000 |
| Market Analysis |
Market Cap
|
853,600,476 |
|
Price
|
4.58 |
|
BVPS
|
10.64 |
|
PB
|
0.43 |
|
EPS
|
-2.22 |
|
PS
|
71133.37 |
|
FCF
|
-398,218,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view FDMT documents filed with the SEC.
FDMT Filings
Clear
